Serum amyloidAoverrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways

Blood

Volumn 117, Issue 14, 2011, Pages 3793-3798

  Nguyen, Khoa D ^a   Macaubas, Claudia ^a   Nadeau, Kari C ^a   Truong, Phi ^a   Yoon, Taejin ^a   Lee, Tzielan ^a   Park, Jane L ^a   Mellins, Elizabeth D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM AMYLOID A; SUPPRESSOR OF CYTOKINE SIGNALING 3; SOCS3 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CLONAL ANERGY; CONTROLLED STUDY; HUMAN; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; CELL CULTURE; CHILD; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CLONAL ANERGY; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 79953815598     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-318832     Document Type: Article

References (22)

1. Lühn K, Simmons CP, Moran E, et al. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med. 2007; 204(5):979-985. (Pubitemid 46798142)
2. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med. 2006;203(2):359-370. (Pubitemid 43290845)
3. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 2003; 299(5609):1033-1036. (Pubitemid 36222922)
4. O'Sullivan BJ, Thomas HE, Pai S, et al. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol. 2006;176(12):7278-7287. (Pubitemid 43849028)
5. Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science. 2008; 320(5880):1220-1224. (Pubitemid 351929511)
6. O'Connor RA, Malpass KH, Anderton SM. The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J Immunol. 2007;179(2):958-966.
7. Tonkin DR, Haskins K. Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner. Eur J Immunol. 2009;39(5):1313-1322.
8. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid Arthritis Rheum. 2004;50(9):2775-2785. (Pubitemid 39209514)
9. Holmén N, Lundgren A, Lundin S, et al. Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis. 2006;12(6):447-456.
10. Su SB, Gong W, Gao JL, et al. A seventransmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med. 1999;189(2):395-402. (Pubitemid 29063260)
11. Baranova IN, Vishnyakova TG, Bocharov AV, et al. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J Biol Chem. 2005;280(9):8031-8040. (Pubitemid 40349701)
12. Cheng N, He R, Tian J, Ye PP, Ye RD. Cutting edge: TLR2 is a functional receptor for acutephase serum amyloid A. J Immunol. 2008;181(1): 22-26.
13. Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A. Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol. 2008; 83(5):1174-1180. (Pubitemid 351960349)
14. Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol. 2008;35(5):752-756. (Pubitemid 351747112)
15. Wong PK, Egan PJ, Croker BA, et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest. 2006;116(6):1571-1581.
16. Gasperini S, Crepaldi L, Calzetti F, et al. Interleukin- 10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal. Eur Cytokine Netw. 2002;13(1):47-53. (Pubitemid 34535571)
17. Barclay JL, Anderson ST,Waters MJ, Curlewis JD. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells. Mol Endocrinol. 2007;21(10):2516-2528. (Pubitemid 47529362)
18. Heller EA, Liu E, Tager AM, et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation. 2006;113(19):2301-2312. (Pubitemid 43947976)
19. Patel S, Chung SH, White G, Bao S, Celermajer DS. The "atheroprotective" mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques. Int J Cardiol. 2010;145(2):183-187.
20. Bunnag S, Allanach K, Jhangri GS, et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant. 2008;8(7):1423-1433. (Pubitemid 351989494)
21. Hillman NH, Moss TJ, Kallapur SG, et al. Brief, large tidal volume ventilation initiates lung injury and a systemic response in fetal sheep. Am J Respir Crit Care Med. 2007;176(6):575-581. (Pubitemid 47403275)
22. Jurawitz MC, Luhrmann A, Tschernig T, Pabst R. Kinetics of regulatory T cells in the ovalbumin asthma model in the rat. Int Arch Allergy Immunol. 2009;149(1):16-24.